Community Fundraising October Wrap-Up
4 November 2019
As we say goodbye to October, it is time again to say thank you to our incredible community fundraisers who are helping us get closer to our goal of zero deaths from melanoma with each event they organise.
Brothers Jack and Sam Glasson wanted to shave their heads in early October to show their appreciation and respect for all melanoma patients. They raised $1500 for MIA – thank you, boys!
Over two nights, Creative for a Cause presented 'Warped', a musical variety show where all proceeds were donated to MIA in loving memory of Diana Perini. The production was a huge success, raising over $10,000! Thank you to everyone who participated and special thanks to Greta Georgiou.
Amelia and Michael Wood have been hosting the Michael Wood Electrical Golf Day for 12 years with many different charity beneficiaries. This year, after the loss of close family friend Janelle to melanoma, they decided to fundraise for MIA. Over $3000 was raised on the day by their 81 players and spectators. About 20 members of Janelle's family made the trip to the town of Jandowae for 'A Day for J', with Janelle's son and 7-year-old grandson driving 800kms to be there! Thank you to all involved.
Matthew Limbrey and Liz Gray both competed in the Bowral Classic, a 120km bicycle race to raise money for MIA, raising almost $1000 between them! Liz also contributed to her fundraiser through the sale of her handcrafted greeting cards.
Adrian Gilchrist has shaved his head each year since 2013 after he lost his father, David, in 2011 to melanoma. This year, he raised $1000 for MIA. Thank you to everyone who donated to 'Bald Gilly'!
Malcolm Price and Elizabeth Liu from Poolwerx Turramurra have both been touched by melanoma in different ways. The team at Poolwerx Turramurra dedicated the last weekend in October to raise funds for MIA through the Poolwerx Turramurra Charity BBQ. They raised $1185 with additional funds still to come from Poolwerx itself. Thank you to everyone involved!
Dr Scot Ebbinghaus chats to us about an exciting clinical trial at MIA and where melanoma treatment is headed in the future.
A new melanoma treatment has been listed on the PBS today, giving another option for advanced melanoma patients.
MIA's Pathology Fellow Dr Louise Jackett tells us why she's joined our fellowship program to learn from the best.
MIA doctors and patient have featured in the final episode of ABC’s ground-breaking series Keeping Australia Alive.
Specialist dermatologists at MIA are researching moles during pregnancy and we are looking for study recruits.
New research is re-writing the textbooks on what we know about melanoma by highlighting the effectiveness of radiotherapy as a treatment, reversing a long-held belief that melanoma was resistant to radiotherapy.
However, Australia's burden of melanoma will stay very high over the next 15 years unless we do more. MIA's Professor Graham Mann explains.
Thank you to everyone involved in making Melanoma March 2016 a huge success
Melanoma March 2016 has officially begun with more than 300 people marching in Rockingham and Devonport.
MIA's new CEO Carole Renouf has been in her role only a month, but is already making plans for the future of MIA.
In the wake of Susie Maroney's recent announcement that she is battling melanoma, CEO Carole Renouf's opinion piece weighs in on the critical need we have in Australia to raise awareness about melanoma.
MIA's Georgina Long has been appointed Professor and awarded a coverted prize in medial research.
Melanoma March 2016 funding will be used to initiate an ambitious new project that will support the best possible care for melanoma patients around Australia through a new data and communication platform.
New research shows long-term survival in group of advanced melanoma patients treated with BRAF inhibitors
New MIA-led research has been published in the Journal of Clinical Oncology.
Melanoma March was officially launched today with the announcement of the national research project funded by the march.
Clinical research undertaken at MIA has been pivotal in supporting the recent Therapeutic Goods Administration approval of Opdivo (nivolumab) for advanced melanoma.
Maddison, the face of our Melanoma March campaign, knows the far-reaching effects that melanoma can have.
MIA's Dermatologist Associate Professor Pascale Guitera answers your most commonly-asked questions about sunscreen.
Statistics released by the Queensland Cancer Registry have revealed that melanoma is the most common cancer in young Queenslanders aged under 35, with rates in young women more than 20 per cent higher than in men.
As 2015 draws to a close, we took the opportunity to speak with Associate Professor Georgina Long to discuss her crucial role at Melanoma Institute Australia, and the current research projects she is working on.